Current disease status-First occurrence of the leukemia Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the leukemia Posts on Medivizor

Immunoglobulin levels at diagnosis and outcomes of patients with chronic lymphocytic leukemia

Posted by on Aug 13, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the relationship between immunoglobulin (Ig) levels and clinical outcomes in patients with chronic lymphocytic leukemia.  This study concluded that levels of IgG and IgA at diagnosis are important prognostic markers for infection in these patients.  Some background Immunoglobulins (Ig)...

Read More

Looking for newly diagnosed patients with acute myelogenous leukemia to test a chemotherapy combination

Posted by on Jul 24, 2019 in Leukemia | 0 comments

In a nutshell This trial is investigating the effectiveness of adding chemotherapy drug venetoclax to a standard chemotherapy treatment for patients with acute myelogenous leukemia (AML). The main outcome for this study would be the maximum amount of the drug that gives the most benefits to patients and the effectiveness of the drug. This study...

Read More

Evaluating strategies to preserve fertility in cancer patients

Posted by on Jul 23, 2019 in Leukemia | 0 comments

In a nutshell This study investigated female fertility preservation (FFP) in cancer patients. They found that FFP should be discussed with all women of reproductive age undergoing cancer treatment. Some background Cancer can have many negative effects on patient health. Infertility is a particular concern for younger female patients. Pregnancy rates...

Read More

Blinatumomab vs chemotherapy in the treatment of relapsed or unresponsive acute lymphoblastic leukemia

Posted by on Jun 23, 2019 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of blinatumomab (Blincyto) with chemotherapy in the treatment of acute lymphoblastic leukemia (ALL). Researchers found the survival was higher with blinatumomab than chemotherapy alone. Some background Patients with unresponsive or relapsed ALL treated with chemotherapy have...

Read More

Looking for older patients with acute myeloid leukemia to test a new treatment combination

Posted by on Jun 14, 2019 in Leukemia | 0 comments

In a nutshell This study is evaluating how well CPI-613 plus chemotherapy works in older patients with acute myeloid leukemia (AML) that has come back or stopped responding to treatment. The main outcome to be measured will be the number of patients who have a complete disappearance of all signs of cancer. This trial is taking place across the United...

Read More

Comparing complete remission in patients with acute myeloid leukemia who receive standard or high-dose chemotherapy

Posted by on Apr 24, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to compare levels of early complete remission in patients with acute myeloid leukemia (AML) treated with standard or sequential high-dose chemotherapy.  This study concluded that sequential high-dose chemotherapy led to early complete remission in these patients.  Some background Sequential high-dose...

Read More

Looking for young patients with B-cell acute lymphoblastic leukemia to test a new T-cell therapy

Posted by on Apr 22, 2019 in Leukemia | 0 comments

In a nutshell This phase 2 trial is evaluating the effectiveness of huCART19 cell therapy in young patients with high-risk B-cell acute lymphoblastic leukemia (ALL). The main outcome to be measured will be survival without a treatment-related complication. This study is being conducted in Philadelphia, Pennsylvania, United States. The details Acute...

Read More

Looking for elderly patients with chronic lymphocytic leukemia to test a treatment combination

Posted by on Mar 16, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of ibrutinib and obinutuzumab with or without venetoclax in the treatment of older patients with chronic lymphocytic leukemia (CLL). The main outcome to be measured will be survival without cancer worsening. This trial is recruiting in the United States. The details Patients with CLL are often...

Read More